Sungho Bea

465 total citations
35 papers, 218 citations indexed

About

Sungho Bea is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Infectious Diseases. According to data from OpenAlex, Sungho Bea has authored 35 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Infectious Diseases. Recurrent topics in Sungho Bea's work include Diabetes Treatment and Management (10 papers), Tuberculosis Research and Epidemiology (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Sungho Bea is often cited by papers focused on Diabetes Treatment and Management (10 papers), Tuberculosis Research and Epidemiology (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Sungho Bea collaborates with scholars based in South Korea, United States and United Kingdom. Sungho Bea's co-authors include Ju‐Young Shin, Young Min Cho, Jae Hyun Bae, Seung Hun Jang, Han Eol Jeong, Ju Hwan Kim, Hyesung Lee, Hyunjin Son, Sun Wook Cho and Sohee Park and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Clinical Endocrinology & Metabolism and Gut.

In The Last Decade

Sungho Bea

31 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sungho Bea South Korea	8	104	83	50	46	44	35	218
Rachel Njeim Lebanon	9	49 0.5×	31 0.4×	69 1.4×	32 0.7×	41 0.9×	19	261
Hun Jee Choe South Korea	7	86 0.8×	47 0.6×	28 0.6×	41 0.9×	20 0.5×	26	236
Philip Newland‐Jones United Kingdom	8	156 1.5×	22 0.3×	49 1.0×	52 1.1×	37 0.8×	9	238
Dragana Lovre United States	10	110 1.1×	27 0.3×	58 1.2×	28 0.6×	38 0.9×	17	265
Roshan Kumar Mahat India	10	58 0.6×	60 0.7×	45 0.9×	24 0.5×	92 2.1×	23	276
Barbara Tartaglino Italy	9	216 2.1×	88 1.1×	63 1.3×	87 1.9×	15 0.3×	20	321
SUBHASH KUMAR WANGNOO India	8	132 1.3×	23 0.3×	34 0.7×	36 0.8×	28 0.6×	38	233
Anissa Atif Mirza India	9	44 0.4×	34 0.4×	38 0.8×	16 0.3×	82 1.9×	41	266
Francisco Idalsoaga Chile	8	64 0.6×	260 3.1×	29 0.6×	40 0.9×	60 1.4×	27	344
Sheraz Fazid Pakistan	6	82 0.8×	49 0.6×	30 0.6×	17 0.4×	12 0.3×	17	220

Countries citing papers authored by Sungho Bea

Since Specialization

Citations

This map shows the geographic impact of Sungho Bea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sungho Bea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sungho Bea more than expected).

Fields of papers citing papers by Sungho Bea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sungho Bea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sungho Bea. The network helps show where Sungho Bea may publish in the future.

Co-authorship network of co-authors of Sungho Bea

This figure shows the co-authorship network connecting the top 25 collaborators of Sungho Bea. A scholar is included among the top collaborators of Sungho Bea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sungho Bea. Sungho Bea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Hyesung, Sungho Bea, Han Eol Jeong, et al.. (2025). Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study. Epidemiology and Health. 47. e2025029–e2025029.

Bea, Sungho, C. Andrew Basham, Heba H Edrees, et al.. (2025). Risk of opioid overdose associated with concurrent use of hydrocodone and CYP3A4-inhibiting calcium channel blockers: a population-based cohort study. American Journal of Epidemiology. 194(12). 3609–3619.

Bea, Sungho, et al.. (2025). Incretin-based drugs and the risk of gallbladder or biliary tract diseases among patients with type 2 diabetes across categories of body mass index: a nationwide cohort study. The Lancet Regional Health - Western Pacific. 56. 101242–101242. 1 indexed citations

Bea, Sungho, Elisabetta Patorno, Georg Hahn, et al.. (2025). Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study. Drug Safety. 49(4). 471–480.

Choi, You‐Jung, Jaehyun Lim, Sungho Bea, et al.. (2024). Thromboembolism after coronavirus disease 2019 vaccination in atrial fibrillation/flutter: a self-controlled case series study. European Heart Journal. 45(32). 2983–2991. 2 indexed citations

Bea, Sungho, et al.. (2024). Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies. Yonsei Medical Journal. 65(2). 120–120. 1 indexed citations

Bea, Sungho, Hyesung Lee, Sohee Park, et al.. (2024). Concomitant Use of Sodium‐Glucose Cotransporter 2 Inhibitors and Overactive Bladder Drugs and the Risk of Urinary Tract Infection. Clinical Pharmacology & Therapeutics. 115(5). 1132–1140. 3 indexed citations

Kim, Seohyun, Sungho Bea, Seung‐Ah Choe, Nam‐Kyong Choi, & Ju‐Young Shin. (2024). Autoimmune disorders reported following COVID-19 vaccination: A disproportionality analysis using the WHO database. European Journal of Clinical Pharmacology. 80(3). 445–453. 4 indexed citations

Bea, Sungho, Jae Hyun Bae, Young Min Cho, et al.. (2024). Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease. Gut. 74(2). 284–294. 23 indexed citations

10.

Bea, Sungho, et al.. (2024). Treatment Patterns and Persistence Among Patients Newly Diagnosed With Migraine in South Korea: A Retrospective Analysis of Health Claims Data. Journal of Clinical Neurology. 20(5). 529–529. 5 indexed citations

11.

Lee, Hyesung, Sungho Bea, Ju Hwan Kim, et al.. (2024). Predictors, mortality, and health outcomes of intensive phase non-adherence to a regimen in patients with drug-susceptible tuberculosis: a nationwide linkage database. Public Health. 229. 167–175. 3 indexed citations

12.

Bea, Sungho, Han Eol Jeong, Kristian B. Filion, et al.. (2023). Outcomes of SGLT-2i and GLP-1RA Therapy Among Patients With Type 2 Diabetes and Varying NAFLD Status. JAMA Network Open. 6(12). e2349856–e2349856. 9 indexed citations

13.

Park, Hae‐Young, Jin‐Won Kwon, Hye‐Lin Kim, et al.. (2023). Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens. Journal of Korean Medical Science. 38(21). e167–e167. 1 indexed citations

14.

Bea, Sungho, Jae Hyeon Kim, Young Min Cho, et al.. (2023). Risk of breakthrough SARS‐CoV‐2 infection and clinical outcomes among vaccinated patients with type 2 diabetes. Diabetes Obesity and Metabolism. 25(9). 2734–2742. 2 indexed citations

15.

Bea, Sungho, Hyesung Lee, Won Suk Choi, et al.. (2023). Risk of mortality and clinical outcomes associated with healthcare delay among patients with tuberculosis. Journal of Infection and Public Health. 16(8). 1313–1321. 2 indexed citations

16.

Jeong, Han Eol, Sohee Park, Yunha Noh, et al.. (2023). Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study. BMC Medicine. 21(1). 47–47. 21 indexed citations

17.

Bea, Sungho, Han Eol Jeong, Sohee Park, et al.. (2023). Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes. JAMA Network Open. 6(9). e2335797–e2335797. 15 indexed citations

18.

Park, Sohee, Han Eol Jeong, Sungho Bea, et al.. (2023). Safety of sodium‐glucose co‐transporter‐2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 25(11). 3248–3258. 3 indexed citations

19.

Chen, Jing, Ju‐Young Shin, Sumitra Shantakumar, et al.. (2023). Burden of Herpes Zoster in Individuals with Immunocompromised Conditions and Autoimmune Diseases in the Republic of Korea: A Nationwide Population-Based Database Study. Infectious Diseases and Therapy. 12(12). 2771–2790. 3 indexed citations

20.

Bea, Sungho, Ju Hwan Kim, Dong Hyun Sinn, et al.. (2023). High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study. Journal of the American Heart Association. 12(8). e028310–e028310. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact